Sign in

CIK 0001006281 · Non-accelerated filer<br>Smaller reporting company

Protalix BioTherapeutics, Inc.

Sign in to watch
Ticker
PLX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
650643773
Phone
201-696-9345
Business address
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
Former names
ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-10-06 Almon Einat Brill VP, Product Development Option exercise · Stock Options (Right to Buy) −70,000 116,848
2010-10-05 Almon Einat Brill VP, Product Development Sale −20,000 $9.08 $182K 0
2010-10-04 Almon Einat Brill VP, Product Development Sale −35,000 $9.02 $316K 0
2010-09-07 Maimon Yossi VP, Chief Financial Officer Sale −31,500 $8.16 $257K 0
2010-09-07 Maimon Yossi VP, Chief Financial Officer Option exercise +70,000 $0.97 $68K 0
2010-09-07 Maimon Yossi VP, Chief Financial Officer Option exercise · Stock Options (Right to Buy) −70,000 153,733
2010-09-07 Almon Einat Brill VP, Product Development Sale −22,500 $8.16 $184K 0
2010-09-07 Almon Einat Brill VP, Product Development Option exercise +4,740 $0.40 $2K 0
2010-09-07 Almon Einat Brill VP, Product Development Option exercise +45,260 $0.97 $44K 0
2010-09-07 Almon Einat Brill VP, Product Development Option exercise · Stock Options (Right to Buy) −4,740 0
2010-09-07 Almon Einat Brill VP, Product Development Option exercise · Stock Options (Right to Buy) −45,260 186,848
2010-09-03 Maimon Yossi VP, Chief Financial Officer Sale −38,500 $8.00 $308K 0
2010-09-03 Almon Einat Brill VP, Product Development Sale −27,500 $8.00 $220K 0
2010-08-29 Palash Tzvi Chief Operating Officer Grant or award · Stock Options (Right to Buy) +160,000 160,000
2010-08-06 Shaaltiel Yoseph Executive VP, R&D Sale −4,619 $7.00 $32K 763,754
2010-08-05 Shaaltiel Yoseph Executive VP, R&D Sale −48,408 $7.00 $339K 768,373
2010-06-21 Shaaltiel Yoseph Executive VP, R&D Sale −52,973 $7.00 $371K 816,781
2010-04-29 Shaaltiel Yoseph Executive VP, R&D Sale −12,691 $7.00 $89K 869,754
2010-04-14 Shaaltiel Yoseph Executive VP, R&D Sale −1,309 $7.00 $9K 882,445
2010-03-25 Shaaltiel Yoseph Executive VP, R&D Sale −50,000 $7.00 $350K 883,754

Page 9 of 33 · 654 trades